1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Glucose Testing 1.2.3 Hb1Ac Testing 1.2.4 Infectious Disease Testing 1.2.5 Coagulation 1.2.6 Fertility 1.2.7 Cardiac markers 1.2.8 Primary care systems 1.2.9 Hematology 1.2.10 Decentralized Clinical Chemistry 1.2.11 Feces 1.3 Market by Application 1.3.1 Global Point of Care Diagnostics (POCD) Market Share by Application: 2020 VS 2026 1.3.2 Clinics 1.3.3 Hospitals 1.3.4 Assisted Living Healthcare Facilities 1.3.5 Laboratory 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2015-2026) 2.2 Global Point of Care Diagnostics (POCD) Growth Trends by Regions 2.2.1 Point of Care Diagnostics (POCD) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Point of Care Diagnostics (POCD) Historic Market Share by Regions (2015-2020) 2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Point of Care Diagnostics (POCD) Players by Market Size 3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2015-2020) 3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2015-2020) 3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue 3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio 3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2019 3.5 Key Players Point of Care Diagnostics (POCD) Area Served 3.6 Key Players Point of Care Diagnostics (POCD) Product Solution and Service 3.7 Date of Enter into Point of Care Diagnostics (POCD) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Point of Care Diagnostics (POCD) Breakdown Data by Type (2015-2026) 4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2015-2020) 4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2021-2026) 5 Point of Care Diagnostics (POCD) Breakdown Data by Application (2015-2026) 5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2015-2020) 5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Point of Care Diagnostics (POCD) Market Size (2015-2026) 6.2 North America Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) 6.3 North America Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) 6.4 North America Point of Care Diagnostics (POCD) Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Point of Care Diagnostics (POCD) Market Size (2015-2026) 7.2 Europe Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) 7.3 Europe Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) 7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Point of Care Diagnostics (POCD) Market Size (2015-2026) 8.2 China Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) 8.3 China Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) 8.4 China Point of Care Diagnostics (POCD) Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Point of Care Diagnostics (POCD) Market Size (2015-2026) 9.2 Japan Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) 9.3 Japan Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) 9.4 Japan Point of Care Diagnostics (POCD) Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Point of Care Diagnostics (POCD) Market Size (2015-2026) 10.2 Southeast Asia Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) 10.3 Southeast Asia Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) 10.4 Southeast Asia Point of Care Diagnostics (POCD) Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Point of Care Diagnostics (POCD) Introduction 11.1.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)) 11.1.5 Roche Recent Development 11.2 Abbott 11.2.1 Abbott Company Details 11.2.2 Abbott Business Overview 11.2.3 Abbott Point of Care Diagnostics (POCD) Introduction 11.2.4 Abbott Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.2.5 Abbott Recent Development 11.3 BioMérieux 11.3.1 BioMérieux Company Details 11.3.2 BioMérieux Business Overview 11.3.3 BioMérieux Point of Care Diagnostics (POCD) Introduction 11.3.4 BioMérieux Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.3.5 BioMérieux Recent Development 11.4 Abaxis 11.4.1 Abaxis Company Details 11.4.2 Abaxis Business Overview 11.4.3 Abaxis Point of Care Diagnostics (POCD) Introduction 11.4.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.4.5 Abaxis Recent Development 11.5 Siemens Healthineers 11.5.1 Siemens Healthineers Company Details 11.5.2 Siemens Healthineers Business Overview 11.5.3 Siemens Healthineers Point of Care Diagnostics (POCD) Introduction 11.5.4 Siemens Healthineers Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.5.5 Siemens Healthineers Recent Development 11.6 QIAGEN 11.6.1 QIAGEN Company Details 11.6.2 QIAGEN Business Overview 11.6.3 QIAGEN Point of Care Diagnostics (POCD) Introduction 11.6.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.6.5 QIAGEN Recent Development 11.7 Danaher 11.7.1 Danaher Company Details 11.7.2 Danaher Business Overview 11.7.3 Danaher Point of Care Diagnostics (POCD) Introduction 11.7.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.7.5 Danaher Recent Development 11.8 Instrumentation Laboratory 11.8.1 Instrumentation Laboratory Company Details 11.8.2 Instrumentation Laboratory Business Overview 11.8.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction 11.8.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.8.5 Instrumentation Laboratory Recent Development 11.9 Nova Biomedical 11.9.1 Nova Biomedical Company Details 11.9.2 Nova Biomedical Business Overview 11.9.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction 11.9.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.9.5 Nova Biomedical Recent Development 11.10 Quidel 11.10.1 Quidel Company Details 11.10.2 Quidel Business Overview 11.10.3 Quidel Point of Care Diagnostics (POCD) Introduction 11.10.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 11.10.5 Quidel Recent Development 11.11 Trinity Biotech 10.11.1 Trinity Biotech Company Details 10.11.2 Trinity Biotech Business Overview 10.11.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction 10.11.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 10.11.5 Trinity Biotech Recent Development 11.12 Sekisui Diagnostics 10.12.1 Sekisui Diagnostics Company Details 10.12.2 Sekisui Diagnostics Business Overview 10.12.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction 10.12.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 10.12.5 Sekisui Diagnostics Recent Development 11.13 OraSure Technologies 10.13.1 OraSure Technologies Company Details 10.13.2 OraSure Technologies Business Overview 10.13.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction 10.13.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 10.13.5 OraSure Technologies Recent Development 11.14 Johnson & Johnson 10.14.1 Johnson & Johnson Company Details 10.14.2 Johnson & Johnson Business Overview 10.14.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction 10.14.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 10.14.5 Johnson & Johnson Recent Development 11.15 Becton Dickinson 10.15.1 Becton Dickinson Company Details 10.15.2 Becton Dickinson Business Overview 10.15.3 Becton Dickinson Point of Care Diagnostics (POCD) Introduction 10.15.4 Becton Dickinson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) 10.15.5 Becton Dickinson Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Glucose Testing Table 4. Key Players of Hb1Ac Testing Table 5. Key Players of Infectious Disease Testing Table 6. Key Players of Coagulation Table 7. Key Players of Fertility Table 8. Key Players of Cardiac markers Table 9. Key Players of Primary care systems Table 10. Key Players of Hematology Table 11. Key Players of Decentralized Clinical Chemistry Table 12. Key Players of Feces Table 13. Global Point of Care Diagnostics (POCD) Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Point of Care Diagnostics (POCD) Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Point of Care Diagnostics (POCD) Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Point of Care Diagnostics (POCD) Market Share by Regions (2015-2020) Table 17. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Point of Care Diagnostics (POCD) Market Share by Regions (2021-2026) Table 19. Point of Care Diagnostics (POCD) Market Market Trends Table 20. Point of Care Diagnostics (POCD) Market Drivers Table 21. Point of Care Diagnostics (POCD) Market Challenges Table 22. Point of Care Diagnostics (POCD) Market Restraints Table 23. Global Point of Care Diagnostics (POCD) Revenue by Players (2015-2020) (US$ Million) Table 24. Global Point of Care Diagnostics (POCD) Market Share by Players (2015-2020) Table 25. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Diagnostics (POCD) as of 2019) Table 26. Global Point of Care Diagnostics (POCD) by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Point of Care Diagnostics (POCD) Product Solution and Service Table 29. Mergers & Acquisitions, Expansion Plans Table 30. Global Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (US$ Million) Table 31. Global Point of Care Diagnostics (POCD) Market Size Share by Type (2015-2020) Table 32. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2021-2026) Table 33. Global Point of Care Diagnostics (POCD) Market Size Share by Application (2015-2020) Table 34. Global Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (US$ Million) Table 35. Global Point of Care Diagnostics (POCD) Market Size Share by Application (2021-2026) Table 36. North America Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (US$ Million) Table 37. North America Point of Care Diagnostics (POCD) Market Share by Type (2015-2020) Table 38. North America Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (US$ Million) Table 39. North America Point of Care Diagnostics (POCD) Market Share by Application (2015-2020) Table 40. North America Point of Care Diagnostics (POCD) Market Size by Country (US$ Million) (2015-2020) Table 41. North America Point of Care Diagnostics (POCD) Market Share by Country (2015-2020) Table 42. Europe Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (US$ Million) Table 43. Europe Point of Care Diagnostics (POCD) Market Share by Type (2015-2020) Table 44. Europe Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (US$ Million) Table 45. Europe Point of Care Diagnostics (POCD) Market Share by Application (2015-2020) Table 46. Europe Point of Care Diagnostics (POCD) Market Size by Country (US$ Million) (2015-2020) Table 47. Europe Point of Care Diagnostics (POCD) Market Share by Country (2015-2020) Table 48. China Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (US$ Million) Table 49. China Point of Care Diagnostics (POCD) Market Share by Type (2015-2020) Table 50. China Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (US$ Million) Table 51. China Point of Care Diagnostics (POCD) Market Share by Application (2015-2020) Table 52. China Point of Care Diagnostics (POCD) Market Size by Region (US$ Million) (2015-2020) Table 53. China Point of Care Diagnostics (POCD) Market Share by Region (2015-2020) Table 54. Japan Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (US$ Million) Table 55. Japan Point of Care Diagnostics (POCD) Market Share by Type (2015-2020) Table 56. Japan Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (US$ Million) Table 57. Japan Point of Care Diagnostics (POCD) Market Share by Application (2015-2020) Table 58. Japan Point of Care Diagnostics (POCD) Market Size by Country (US$ Million) (2015-2020) Table 59. Japan Point of Care Diagnostics (POCD) Market Share by Country (2015-2020) Table 60. Southeast Asia Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (US$ Million) Table 61. Southeast Asia Point of Care Diagnostics (POCD) Market Share by Type (2015-2020) Table 62. Southeast Asia Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (US$ Million) Table 63. Southeast Asia Point of Care Diagnostics (POCD) Market Share by Application (2015-2020) Table 64. Southeast Asia Point of Care Diagnostics (POCD) Market Size by Country (US$ Million) (2015-2020) Table 65. Southeast Asia Point of Care Diagnostics (POCD) Market Share by Country (2015-2020) Table 66. Roche Company Details Table 67. Roche Business Overview Table 68. Roche Product Table 69. Roche Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 70. Roche Recent Development Table 71. Abbott Company Details Table 72. Abbott Business Overview Table 73. Abbott Product Table 74. Abbott Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 75. Abbott Recent Development Table 76. BioMérieux Company Details Table 77. BioMérieux Business Overview Table 78. BioMérieux Product Table 79. BioMérieux Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 80. BioMérieux Recent Development Table 81. Abaxis Company Details Table 82. Abaxis Business Overview Table 83. Abaxis Product Table 84. Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 85. Abaxis Recent Development Table 86. Siemens Healthineers Company Details Table 87. Siemens Healthineers Business Overview Table 88. Siemens Healthineers Product Table 89. Siemens Healthineers Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 90. Siemens Healthineers Recent Development Table 91. QIAGEN Company Details Table 92. QIAGEN Business Overview Table 93. QIAGEN Product Table 94. QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 95. QIAGEN Recent Development Table 96. Danaher Company Details Table 97. Danaher Business Overview Table 98. Danaher Product Table 99. Danaher Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 100. Danaher Recent Development Table 101. Instrumentation Laboratory Business Overview Table 102. Instrumentation Laboratory Product Table 103. Instrumentation Laboratory Company Details Table 104. Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 105. Instrumentation Laboratory Recent Development Table 106. Nova Biomedical Company Details Table 107. Nova Biomedical Business Overview Table 108. Nova Biomedical Product Table 109. Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 110. Nova Biomedical Recent Development Table 111. Quidel Company Details Table 112. Quidel Business Overview Table 113. Quidel Product Table 114. Quidel Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 115. Quidel Recent Development Table 116. Trinity Biotech Company Details Table 117. Trinity Biotech Business Overview Table 118. Trinity Biotech Product Table 119. Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 120. Trinity Biotech Recent Development Table 121. Sekisui Diagnostics Company Details Table 122. Sekisui Diagnostics Business Overview Table 123. Sekisui Diagnostics Product Table 124. Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 125. Sekisui Diagnostics Recent Development Table 126. OraSure Technologies Company Details Table 127. OraSure Technologies Business Overview Table 128. OraSure Technologies Product Table 129. OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 130. OraSure Technologies Recent Development Table 131. Johnson & Johnson Company Details Table 132. Johnson & Johnson Business Overview Table 133. Johnson & Johnson Product Table 134. Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 135. Johnson & Johnson Recent Development Table 136. Becton Dickinson Company Details Table 137. Becton Dickinson Business Overview Table 138. Becton Dickinson Product Table 139. Becton Dickinson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (US$ Million) Table 140. Becton Dickinson Recent Development Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Global Point of Care Diagnostics (POCD) Market Share by Type: 2020 VS 2026 Figure 2. Glucose Testing Features Figure 3. Hb1Ac Testing Features Figure 4. Infectious Disease Testing Features Figure 5. Coagulation Features Figure 6. Fertility Features Figure 7. Cardiac markers Features Figure 8. Primary care systems Features Figure 9. Hematology Features Figure 10. Decentralized Clinical Chemistry Features Figure 11. Feces Features Figure 12. Global Point of Care Diagnostics (POCD) Market Share by Application: 2020 VS 2026 Figure 13. Clinics Case Studies Figure 14. Hospitals Case Studies Figure 15. Assisted Living Healthcare Facilities Case Studies Figure 16. Laboratory Case Studies Figure 17. Point of Care Diagnostics (POCD) Report Years Considered Figure 18. Global Point of Care Diagnostics (POCD) Market Size (US$ Million), YoY Growth 2015-2026 Figure 19. Global Point of Care Diagnostics (POCD) Market Share by Regions: 2020 VS 2026 Figure 20. Global Point of Care Diagnostics (POCD) Market Share by Regions (2021-2026) Figure 21. Global Point of Care Diagnostics (POCD) Market Share by Players in 2019 Figure 22. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Diagnostics (POCD) as of 2019 Figure 23. The Top 10 and 5 Players Market Share by Point of Care Diagnostics (POCD) Revenue in 2019 Figure 24. North America Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. United States Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Canada Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Europe Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Germany Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. France Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. U.K. Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Italy Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Russia Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Nordic Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Europe Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Asia-Pacific Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. China Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Japan Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. South Korea Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Southeast Asia Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. India Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Australia Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Asia-Pacific Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Latin America Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Mexico Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Brazil Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. Middle East & Africa Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 47. Turkey Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 48. Saudi Arabia Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 49. UAE Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 50. Rest of Middle East & Africa Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 51. Roche Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 52. Abbott Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 53. BioMérieux Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 54. Abaxis Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 55. Siemens Healthineers Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 56. QIAGEN Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 57. Danaher Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 58. Instrumentation Laboratory Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 59. Nova Biomedical Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 60. Quidel Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 61. Trinity Biotech Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 62. Sekisui Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 63. OraSure Technologies Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 64. Johnson & Johnson Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 65. Becton Dickinson Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2015-2020) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Roche Abbott BioMérieux Abaxis Siemens Healthineers QIAGEN Danaher Instrumentation Laboratory Nova Biomedical Quidel Trinity Biotech Sekisui Diagnostics OraSure Technologies Johnson & Johnson Becton Dickinson